DLGAP1-AS5

Across TCGA pan-cancer cohorts, DLGAP1-AS5 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated DLGAP1-AS5 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher DLGAP1-AS5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated DLGAP1-AS5 expression acts as an unfavorable survival marker, although some lineages such as MESO and BRCA show a favorable association.

THCA, MESO, and UCEC are the cancer types where DLGAP1-AS5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	III,IV	0.170	0.729	<.001	99	view →
MESO	DFS	Median	All	0.468	0.275	<.001	93	view →
UCEC	DFS	Tertile	II,III,IV	0.588	0.793	.001	84	view →
THYM	OS	Quartile	All	0.898	0.989	<.001	52	view →
KIRP	DFS	Tertile	All	0.409	0.634	.001	45	view →
BRCA	OS	Median	All	0.635	0.512	<.001	34	view →
KICH	DFS	Tertile	III,IV	0.254	0.853	.001	33	view →
UVM	OS	Tertile	All	0.293	0.697	.017	33	view →
CESC	DFS	Quartile	IV	0.855	0.314	.002	32	view →
ACC	DFS	Quartile	All	0.139	0.676	.001	26	view →
LGG	OS	Median	All	0.946	0.849	<.001	25	view →
COAD	DFS	Tertile	II,III,IV	0.379	0.756	.004	24	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

DLGAP1-AS5–THCA (DFS)

Open the THCA breakdown →